2021
DOI: 10.1016/j.arr.2021.101302
|View full text |Cite
|
Sign up to set email alerts
|

Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 192 publications
1
8
0
Order By: Relevance
“…Cognitive ability is the capacity of the human brain to process, store and extract information ( Hunter, 1986 ). Cognitive decline is a progressive neurodegenerative disease associated with increasing age among the elderly ( Li et al, 2019 ; Kioussis et al, 2021 ; Liu et al, 2021 ). The aggravation of cognitive decline is likely to lead to Alzheimer’s disease, dementia, and death ( Backman et al, 2005 ; Prince et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…Cognitive ability is the capacity of the human brain to process, store and extract information ( Hunter, 1986 ). Cognitive decline is a progressive neurodegenerative disease associated with increasing age among the elderly ( Li et al, 2019 ; Kioussis et al, 2021 ; Liu et al, 2021 ). The aggravation of cognitive decline is likely to lead to Alzheimer’s disease, dementia, and death ( Backman et al, 2005 ; Prince et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…mTORC1 is one of the most studied amino acid nutrient sensing signaling pathwys and plays a key role in both Aβ and TAU pathologies. Aβ accumulation has been associated to the overactivation of mTORC1 signaling, whilst mTOR signaling inhibition leads to reduced Aβ levels ( Caccamo et al, 2010 ; Kioussis et al, 2021 ). Moreover, accumulating evidence suggests that mTOR activation enhances TAU pathology via autophagy inhibition which, in turn, enhances Aβ accumulation ( Tramutola et al, 2017 ), that further promotes TAU hyperphosphorylation.…”
Section: Defects Of Nutrient Signaling and Autophagy In Alzheimer’s D...mentioning
confidence: 99%
“…Andrea Maier, National University of Singapore, Singapore, stressed the need for an unbiased standardized characterization and reporting of research outcome in the form of a minimum required dataset and trial networks to combat the poor transition currently seen. Additionally, she suggested drug repurposing as a relatively cheap and faster way for new age-related treatments [59,60]. The great benefit of drug repurposing was also highlighted by Nir Barzilai, Albert Einstein College of Medicine, USA, who studies the repurposing of FDA approved drugs such as metformin and canagliflozin [61].…”
Section: Agingmentioning
confidence: 99%